BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20083244)

  • 1. Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol.
    Fischer Jde S; Liao L; Carvalho PC; Barbosa VC; Domont GB; Carvalho Mda G; Yates JR
    J Proteomics; 2010 Mar; 73(5):1018-27. PubMed ID: 20083244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol.
    de Saldanha da Gama Fischer J; Costa Carvalho P; da Fonseca CO; Liao L; Degrave WM; da Gloria da Costa Carvalho M; Yates JR; Domont GB
    J Proteome Res; 2011 Jan; 10(1):153-60. PubMed ID: 20806975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
    Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
    Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the Antiproliferative Activity of Perillyl Alcohol against Glioblastoma Cell Lines through Synergistic Formulation with Natural Oils.
    Alharbi WS; Alshehri AA; Ahmed TA; Shadab M; Almehmady AM; Alshabibi MA; Altamimi RM; El-Say KM
    Curr Pharm Des; 2024; 30(14):1075-1084. PubMed ID: 38532602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
    Fischer Jde S; Carvalho PC; Neves-Ferreira AG; da Fonseca CO; Perales J; Carvalho Mda G; Domont GB
    J Exp Ther Oncol; 2008; 7(4):285-90. PubMed ID: 19227008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects.
    Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol.
    Garcia DG; de Castro-Faria-Neto HC; da Silva CI; de Souza e Souza KF; Gonçalves-de-Albuquerque CF; Silva AR; de Amorim LM; Freire AS; Santelli RE; Diniz LP; Gomes FC; Faria MV; Burth P
    Mol Cancer; 2015 May; 14():105. PubMed ID: 25976744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
    Clark SS; Zhong L; Filiault D; Perman S; Ren Z; Gould M; Yang X
    Clin Cancer Res; 2003 Oct; 9(12):4494-504. PubMed ID: 14555523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
    da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells.
    Chan NL; Wang H; Wang Y; Leung HY; Leung LK
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):98-104. PubMed ID: 16307765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis.
    Chaudhary SC; Alam MS; Siddiqui MS; Athar M
    Chem Biol Interact; 2009 May; 179(2-3):145-53. PubMed ID: 19161993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer.
    Song X; Xie L; Wang X; Zeng Q; Chen TC; Wang W; Song X
    Sci Rep; 2016 Mar; 6():22762. PubMed ID: 26949038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.
    Faria GM; Soares IDP; D'Alincourt Salazar M; Amorim MR; Pessoa BL; da Fonseca CO; Quirico-Santos T
    BMC Cancer; 2020 Apr; 20(1):294. PubMed ID: 32264844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
    Zhang R; Banik NL; Ray SK
    Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.
    Afshordel S; Kern B; Clasohm J; König H; Priester M; Weissenberger J; Kögel D; Eckert GP
    Pharmacol Res; 2015 Jan; 91():69-77. PubMed ID: 25497898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perillyl alcohol and heat shock treatment in gene expression of human lung adenocarcinoma cell line A549.
    Fischer Jde S; Carvalho PC; Gattass CR; Paschoal EM; da Mota e Silva MS; Carvalho Mda G
    J Exp Ther Oncol; 2006; 5(4):301-7. PubMed ID: 17024970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perillyl alcohol causes G1 arrest through p15(INK4b) and p21(WAF1/Cip1) induction.
    Koyama M; Sowa Y; Hitomi T; Iizumi Y; Watanabe M; Taniguchi T; Ichikawa M; Sakai T
    Oncol Rep; 2013 Feb; 29(2):779-84. PubMed ID: 23233050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway.
    Berchtold CM; Chen KS; Miyamoto S; Gould MN
    Cancer Res; 2005 Sep; 65(18):8558-66. PubMed ID: 16166337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells.
    Stayrook KR; McKinzie JH; Barbhaiya LH; Crowell PL
    Anticancer Res; 1998; 18(2A):823-8. PubMed ID: 9615726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
    da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.